Zealand Pharma currently anticipates expenses in the variety of DKK 1250-1350 million.
发布者：BY MARKETWIRE，转转请注明出处：https://robotalks.cn/zealand-pharma-boosts-development-of-obesity-drugs-and-sees-higher-operating-costs-in-2024/
Zealand Pharma boosts development of obesity drugs and sees higher operating costs in 2024
赞 (0)
关于作者
Demant CEO on cost-cutting measures: Provides some good and clear savings
上一篇
15 8 月, 2024 7:18 下午
A mathematical characterization of minimally sufficient robot brains
下一篇
15 8 月, 2024
相关推荐
-
SmartRent Launches $10M Investment Program to Fuel Next-Level Innovation and Customer Success
SCOTTSDALE, Ariz.–(ORGANIZATION CORD)– $SMRT #multifamily– The $10 million financial investment will originally concentrate on driving advancement, brand-new func…
-
Dutch startup OpusFlow secures €1.7 million to streamline sustainable installers’ operations
Deventer-based OpusFlow, an introducing all-in-one ERP option for lasting installers revealed a EUR1.7 million financial investment from B2B SaaS capitalist Height. Released in Nov…
-
SHARGE Unveils ICEMAG 2: World's First Qi2 Power Bank with Active Cooling
SHENZHEN, China–(BUSINESS WIRE)–SHARGE, a leader in power supply innovation, proudly launches the highly anticipated ICEMAG 2 power bank, redefining wireless charging w…
-
NEXCOM Unveiling NexMOV-2 Innovations and Next-Gen AI Robotics Technology at CES 2025
Participants can check out North Hall cubicle # 9071 at CES 2025 to discover the innovation behind the NexMOV-2, provided by NexAIoT in cooperation with Kneron
-
Bavarian Nordic wins 150,000-dose Mpox vaccination order from UK authorities
In the U.K., they are mosting likely to immunize teams that go to greater threat of obtaining revealed to mpox.
